Vitiligo-like depigmentation following neoadjuvant chemotherapy combined with pembrolizumab in early triple-negative breast cancer: a case report
BackgroundTriple-negative breast cancer (TNBC) is a biologically aggressive subtype of breast cancer associated with an unfavourable prognosis. In recent years, the combination of immune checkpoint inhibitors with neoadjuvant chemotherapy has become a standard treatment strategy for selected patient...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2026-07-01
|
| Seri Bilgileri: | Frontiers in Oncology |
| Konular: | |
| Online Erişim: | https://www.frontiersin.org/articles/10.3389/fonc.2026.1817257/full |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|